Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2005
11/24/2005CA2566703A1 Methods of inhibiting proinflammatory cytokine expression using ghrelin
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2566210A1 Oxo-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2561859A1 Beta-carbolines useful for treating inflammatory disease
11/24/2005CA2508065A1 Antiproliferative drug and delivery device
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1598076A1 Interleukin 6 production inhibitor
11/23/2005EP1598072A1 Medical drug containing fine particle of noble metal
11/23/2005EP1598057A1 Combination of acid protease enzymes and acidic buffers and uses thereof
11/23/2005EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
11/23/2005EP1597299A2 Carbonate esters of polyethylene glycol activated by means of oxalate esters
11/23/2005EP1597265A2 Glycosolated enkephalin agents
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1596860A2 Novel compounds
11/23/2005EP1596856A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/23/2005EP1596847A1 New combination
11/23/2005EP1596816A2 Zubereitungen eines extrakt von eperua falcata und/oder dessen inhaltstoffe enthaltend
11/23/2005EP1596811A2 Compositions and methods to modulate immune and inflammatory responses
11/23/2005EP1463721B1 Compounds for imaging alzheimer's disease
11/23/2005EP1455849B1 A wound care device
11/23/2005EP1381628B1 Inflammation-specific peptides and the uses thereof
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor
11/23/2005EP1165066B1 Use of lipoxin compounds for inhibiting of tnf-alpha initiated neutrophil response
11/23/2005CN1701071A Therapeutic agents useful for treating pain
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
11/23/2005CN1700922A 3, 10, and 12a substituted tetracycline compounds
11/23/2005CN1700914A The prevention and treatment for inflammatory disease in oral-cavity mucosa
11/23/2005CN1700913A Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
11/23/2005CN1698602A Usage of pyrazoline derivant in the drug preparation for preventing and/or treating cell breeding disease
11/23/2005CN1228446C Conotoxin MVII A and Trx fusion protein and its expression and application
11/23/2005CN1228346C Short peptide and its derivative and medicine with them as active component and use thereof
11/23/2005CN1228338C Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
11/23/2005CN1228087C Medicinal preparation and its prepn. and application
11/23/2005CN1228080C Blood activating Chinese medicinal composition in traumatology department and its preparing process
11/23/2005CN1228068C Medicated liquor for dispelling wind, removing alampness and relieving pain, and preparation process thereof
11/23/2005CN1228064C Externally applied medicine for relieving pain and diminishing inflammation
11/23/2005CN1228061C Specific Meng medicine pill specially adapted for treating rheumatism
11/22/2005US6967248 Crystalline forms of meloxicam and processes for their preparation and interconversion
11/22/2005US6967245 Ucp5
11/22/2005US6967214 Inhibitors of IMPDH enzyme
11/22/2005US6967213 Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same
11/22/2005US6967210 Multiple sclerosis, brain disorders, analgesics
11/22/2005US6967197 Also used in production of tumor necrosis factor alpha
11/22/2005US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces
11/17/2005WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents
11/17/2005WO2005107748A2 Method of tonic treatment with oxyphenbutazone derivatives
11/17/2005WO2005107731A1 Remedies containing vitamin k2 as the active ingredient
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005US20050256326 Process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256311 Pyrimidine compounds
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256143 Purine nucleosides
11/17/2005US20050256140 Condensed pyridines and pyrimidines with tie2 (tek) activity
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255518 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/17/2005DE10392697T5 Herstellung und Standardisierung von immunmodulierenden Peptid-verknüpften Glucanen mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor Preparation and standardization of immunomodulating peptide-linked glucans with detectable oral absorbability from Coriolus Versicolor
11/17/2005CA2566398A1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
11/17/2005CA2566228A1 Method of tonic treatment with oxyphenbutazone derivatives
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1595869A1 Pyrimidine derivatives
11/16/2005EP1594854A2 Thiazolyl-based compounds useful as kinase inhibitors
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594517A2 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2005EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/16/2005EP1594499A1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
11/16/2005EP1594486A2 Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same
11/16/2005EP1594441A2 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1363608B1 Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleep disturbances
11/16/2005EP1289517B1 Pharmaceutical compositions comprising cannabidiol derivatives
11/16/2005EP1222191B1 Benzodiazepin derivatives, the production and use thereof
11/16/2005EP1220661B1 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005EP1196450B1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/16/2005EP1146035B1 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
11/16/2005EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors
11/16/2005EP1107767B1 Use of selenium for treating systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005EP0556207B2 Modified human tnfalpha (tumor necrosis factor alpha) receptor
11/16/2005CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 1272